Human RANKL/OPGL/TNFSF11 (CD254) (Fc Tag) recombinant protein

Cat.#: 503998

Size:

Special Price 341.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Human RANKL/OPGL/TNFSF11 (CD254) (Fc Tag) recombinant protein
  • Documents
  • Description
    Tumor necrosis factor ligand superfamily member 11, also known as Receptor activator of nuclear factor kappa-B ligand, Osteoprotegerin ligand, TNFSF11, RANKL, TRANCE, OPGL and CD254, is a single-pass type II membrane protein which belongs to the tumor necrosis factor family. The receptor activator of nuclear factor-kappaB ligand (RANKL), its cognate receptor RANK, and its natural decoy receptor osteoprotegerin have been identified as the final effector molecules of osteoclastic bone resorption. RANK and RANKL are key regulators of bone remodeling and regulate T cell/dendritic cell communications, and lymph node formation. Moreover, RANKL and RANK are expressed in mammary gland epithelial cells and control the development of a lactating mammary gland during pregnancy. Genetically, RANKL and RANK are essential for the development and activation of osteoclasts and bone loss in response to virtually all triggers tested. Inhibition of RANKL function via the natural decoy receptor osteoprotegerin (OPG, TNFRSF11B) prevents bone loss in postmenopausal osteoporosis and cancer metastases. Importantly, RANKL appears to be the pathogenetic principle that causes bone and cartilage destruction in arthritis. RANK-RANKL signaling not only activates a variety of downstream signaling pathways required for osteoclast development, but crosstalk with other signaling pathways also fine-tunes bone homeostasis both in normal physiology and disease. In addition, RANKL and RANK have essential roles in lymph node formation, establishment of the thymic microenvironment, and development of a lactating mammary gland during pregnancy.
  • Protein name
    Tumor necrosis factor ligand superfamily member 11
  • Protein short names
    TNFSF11; OPTB2; OPG; HRANKL2; RP11-86N24.2; TRANCE; LY109L; RANKL; SODF; ODF; OPGL; CD254
  • Uniprot ID
    O14788
  • Gene Name
    TNFSF11; OPGL; RANKL; TRANCE
  • Source/Expression Host
    Human Cells
  • Expression Plasmid/cDNA
    A DNA sequence encoding the human TNFSF11 isoform 2 (O14788-2) (Gly 63-Asp 244) was fused with the Fc region of human IgG1 at the N-terminus.
  • Protein Species
    Human
  • Molecular weight
    The recombinant human TNFSF11/Fc chimera is a disulfide-linked homodimeric protein. The reduced monomer consists of 443 amino acids and has a calculated molecular mass of 48.9 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of rh TNFSF11/Fc monomer is approximately 50-55 kDa due to the glycosylation.
  • Purity
    > 86 % as determined by SDS-PAGE
  • Activity
    1. Measured by its binding ability in a functional ELISA. Immobilized human TNFRSF11B-His (Cat:10271-H08H) at 10 μg/ml (100 μl/well) can bind human Fc-TNFSF11 (Cat:11682-H01H) with a linear ranger of 3.125-200 ng/mL.
    2. The bioactivity of hRANKL was determined by measuring the ability of hRANKL to induce TRAP activity in Raw 264.7 cells. The ED50 for this effect is typically 0.1-0.4 μg/mL.
  • Validations

    Human RANKL / OPGL / TNFSF11 / CD254 Protein (Fc Tag) SDS-PAGE

    Human RANKL / OPGL / TNFSF11 / CD254 Protein (Fc Tag) SDS-PAGE

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"